Clark Eliana 4
4 · Intellia Therapeutics, Inc. · Filed Jul 6, 2023
Insider Transaction Report
Form 4
Clark Eliana
EVP, Chief Technical Officer
Transactions
- Sale
Common Stock
2023-07-03$40.51/sh−360$14,584→ 45,146 total
Footnotes (2)
- [F1]Sale of 360 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.51 to $40.52, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 3, 2023 at each separate price.